KDM1A and early-onset autosomal dominant Alzheimer disease: Finally, LSD1 has been reported to be involved in metabolic diseases (Hino et al., 2012) and in central nervous system disorders, such as Alzheimer’s disease and depression (Rusconi et al., 2016).